
No change: table 0 0 5
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value 0: Central Nervous System and Cranial Nerves
  Third character (Operation) is value 5: Destruction: Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent

FY2025: First panel of table 0 0 5
  Fourth character (Body Part) is value 0: Brain
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) has 2 choices.
    First choice is value 3: Laser Interstitial Thermal Therapy
    Second choice is value Z: No Qualifier

FY2025: Second panel of table 0 0 5
  Fourth character (Body Part) is value 0: Brain
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) has 3 choices.
    First choice is value 3: Laser Interstitial Thermal Therapy
    Second choice is value 4: Stereoelectroencephalographic Radiofrequency Ablation
    Third choice is value Z: No Qualifier

No change: Third panel of table 0 0 5
  Fourth character (Body Part) has 23 choices.
    First choice is value 1: Cerebral Meninges
    Second choice is value 2: Dura Mater
    Third choice is value 6: Cerebral Ventricle
    Fourth choice is value 7: Cerebral Hemisphere
    Fifth choice is value 8: Basal Ganglia
    Sixth choice is value 9: Thalamus
    Seventh choice is value A: Hypothalamus
    Eighth choice is value B: Pons
    Ninth choice is value C: Cerebellum
    Tenth choice is value D: Medulla Oblongata
    Eleventh choice is value F: Olfactory Nerve
    Twelfth choice is value G: Optic Nerve
    Thirteenth choice is value H: Oculomotor Nerve
    Fourteenth choice is value J: Trochlear Nerve
    Fifteenth choice is value K: Trigeminal Nerve
    Sixteenth choice is value L: Abducens Nerve
    Seventeenth choice is value M: Facial Nerve
    Eighteenth choice is value N: Acoustic Nerve
    Nineteenth choice is value P: Glossopharyngeal Nerve
    Twentieth choice is value Q: Vagus Nerve
    Twenty-first choice is value R: Accessory Nerve
    Twenty-second choice is value S: Hypoglossal Nerve
    Twenty-third choice is value T: Spinal Meninges
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) is value Z: No Qualifier

FY2025: Fourth panel of table 0 0 5
  Fourth character (Body Part) has 3 choices.
    First choice is value W: Cervical Spinal Cord
    Second choice is value X: Thoracic Spinal Cord
    Third choice is value Y: Lumbar Spinal Cord
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) has 2 choices.
    First choice is value 3: Laser Interstitial Thermal Therapy
    Second choice is value Z: No Qualifier

No change: table 0 0 K
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value 0: Central Nervous System and Cranial Nerves
  Third character (Operation) is value K: Map: Locating the route of passage of electrical impulses and/or locating functional areas in a body part

FY2025: First panel of table 0 0 K
  Fourth character (Body Part) is value 0: Brain
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) is value Z: No Qualifier

FY2025: Second panel of table 0 0 K
  Fourth character (Body Part) is value 0: Brain
  Fifth character (Approach) is value X: External
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) is value 1: Connectomic Analysis

FY2025: Third panel of table 0 0 K
  Fourth character (Body Part) has 7 choices.
    First choice is value 7: Cerebral Hemisphere
    Second choice is value 8: Basal Ganglia
    Third choice is value 9: Thalamus
    Fourth choice is value A: Hypothalamus
    Fifth choice is value B: Pons
    Sixth choice is value C: Cerebellum
    Seventh choice is value D: Medulla Oblongata
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: table 0 4 1
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value 4: Lower Arteries
  Third character (Operation) is value 1: Bypass: Altering the route of passage of the contents of a tubular body part

No change: First panel of table 0 4 1
  Fourth character (Body Part) has 3 choices.
    First choice is value 0: Abdominal Aorta
    Second choice is value C: Common Iliac Artery, Right
    Third choice is value D: Common Iliac Artery, Left
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 5 choices.
    First choice is value 9: Autologous Venous Tissue
    Second choice is value A: Autologous Arterial Tissue
    Third choice is value J: Synthetic Substitute
    Fourth choice is value K: Nonautologous Tissue Substitute
    Fifth choice is value Z: No Device
  Seventh character (Qualifier) has 20 choices.
    First choice is value 0: Abdominal Aorta
    Second choice is value 1: Celiac Artery
    Third choice is value 2: Mesenteric Artery
    Fourth choice is value 3: Renal Artery, Right
    Fifth choice is value 4: Renal Artery, Left
    Sixth choice is value 5: Renal Artery, Bilateral
    Seventh choice is value 6: Common Iliac Artery, Right
    Eighth choice is value 7: Common Iliac Artery, Left
    Ninth choice is value 8: Common Iliac Arteries, Bilateral
    Tenth choice is value 9: Internal Iliac Artery, Right
    Eleventh choice is value B: Internal Iliac Artery, Left
    Twelfth choice is value C: Internal Iliac Arteries, Bilateral
    Thirteenth choice is value D: External Iliac Artery, Right
    Fourteenth choice is value F: External Iliac Artery, Left
    Fifteenth choice is value G: External Iliac Arteries, Bilateral
    Sixteenth choice is value H: Femoral Artery, Right
    Seventeenth choice is value J: Femoral Artery, Left
    Eighteenth choice is value K: Femoral Arteries, Bilateral
    Nineteenth choice is value Q: Lower Extremity Artery
    Twentieth choice is value R: Lower Artery

FY2025: Second panel of table 0 4 1
  Fourth character (Body Part) has 2 choices.
    First choice is value 3: Hepatic Artery
    Second choice is value 4: Splenic Artery
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 5 choices.
    First choice is value 9: Autologous Venous Tissue
    Second choice is value A: Autologous Arterial Tissue
    Third choice is value J: Synthetic Substitute
    Fourth choice is value K: Nonautologous Tissue Substitute
    Fifth choice is value Z: No Device
  Seventh character (Qualifier) has 4 choices.
    First choice is value 3: Renal Artery, Right
    Second choice is value 4: Renal Artery, Left
    Third choice is value 5: Renal Artery, Bilateral
    Fourth choice is value R: Lower Artery

No change: Third panel of table 0 4 1
  Fourth character (Body Part) has 4 choices.
    First choice is value E: Internal Iliac Artery, Right
    Second choice is value F: Internal Iliac Artery, Left
    Third choice is value H: External Iliac Artery, Right
    Fourth choice is value J: External Iliac Artery, Left
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 5 choices.
    First choice is value 9: Autologous Venous Tissue
    Second choice is value A: Autologous Arterial Tissue
    Third choice is value J: Synthetic Substitute
    Fourth choice is value K: Nonautologous Tissue Substitute
    Fifth choice is value Z: No Device
  Seventh character (Qualifier) has 11 choices.
    First choice is value 9: Internal Iliac Artery, Right
    Second choice is value B: Internal Iliac Artery, Left
    Third choice is value C: Internal Iliac Arteries, Bilateral
    Fourth choice is value D: External Iliac Artery, Right
    Fifth choice is value F: External Iliac Artery, Left
    Sixth choice is value G: External Iliac Arteries, Bilateral
    Seventh choice is value H: Femoral Artery, Right
    Eighth choice is value J: Femoral Artery, Left
    Ninth choice is value K: Femoral Arteries, Bilateral
    Tenth choice is value P: Foot Artery
    Eleventh choice is value Q: Lower Extremity Artery

No change: Fourth panel of table 0 4 1
  Fourth character (Body Part) has 2 choices.
    First choice is value K: Femoral Artery, Right
    Second choice is value L: Femoral Artery, Left
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 5 choices.
    First choice is value 9: Autologous Venous Tissue
    Second choice is value A: Autologous Arterial Tissue
    Third choice is value J: Synthetic Substitute
    Fourth choice is value K: Nonautologous Tissue Substitute
    Fifth choice is value Z: No Device
  Seventh character (Qualifier) has 9 choices.
    First choice is value H: Femoral Artery, Right
    Second choice is value J: Femoral Artery, Left
    Third choice is value K: Femoral Arteries, Bilateral
    Fourth choice is value L: Popliteal Artery
    Fifth choice is value M: Peroneal Artery
    Sixth choice is value N: Posterior Tibial Artery
    Seventh choice is value P: Foot Artery
    Eighth choice is value Q: Lower Extremity Artery
    Ninth choice is value S: Lower Extremity Vein

No change: Fifth panel of table 0 4 1
  Fourth character (Body Part) has 2 choices.
    First choice is value K: Femoral Artery, Right
    Second choice is value L: Femoral Artery, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device) is value J: Synthetic Substitute
  Seventh character (Qualifier) has 2 choices.
    First choice is value Q: Lower Extremity Artery
    Second choice is value S: Lower Extremity Vein

No change: Sixth panel of table 0 4 1
  Fourth character (Body Part) has 2 choices.
    First choice is value M: Popliteal Artery, Right
    Second choice is value N: Popliteal Artery, Left
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 5 choices.
    First choice is value 9: Autologous Venous Tissue
    Second choice is value A: Autologous Arterial Tissue
    Third choice is value J: Synthetic Substitute
    Fourth choice is value K: Nonautologous Tissue Substitute
    Fifth choice is value Z: No Device
  Seventh character (Qualifier) has 5 choices.
    First choice is value L: Popliteal Artery
    Second choice is value M: Peroneal Artery
    Third choice is value P: Foot Artery
    Fourth choice is value Q: Lower Extremity Artery
    Fifth choice is value S: Lower Extremity Vein

No change: Seventh panel of table 0 4 1
  Fourth character (Body Part) has 2 choices.
    First choice is value M: Popliteal Artery, Right
    Second choice is value N: Popliteal Artery, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device) is value J: Synthetic Substitute
  Seventh character (Qualifier) has 2 choices.
    First choice is value Q: Lower Extremity Artery
    Second choice is value S: Lower Extremity Vein

No change: Eighth panel of table 0 4 1
  Fourth character (Body Part) has 4 choices.
    First choice is value P: Anterior Tibial Artery, Right
    Second choice is value Q: Anterior Tibial Artery, Left
    Third choice is value R: Posterior Tibial Artery, Right
    Fourth choice is value S: Posterior Tibial Artery, Left
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value J: Synthetic Substitute
  Seventh character (Qualifier) has 2 choices.
    First choice is value Q: Lower Extremity Artery
    Second choice is value S: Lower Extremity Vein

No change: Ninth panel of table 0 4 1
  Fourth character (Body Part) has 4 choices.
    First choice is value T: Peroneal Artery, Right
    Second choice is value U: Peroneal Artery, Left
    Third choice is value V: Foot Artery, Right
    Fourth choice is value W: Foot Artery, Left
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 5 choices.
    First choice is value 9: Autologous Venous Tissue
    Second choice is value A: Autologous Arterial Tissue
    Third choice is value J: Synthetic Substitute
    Fourth choice is value K: Nonautologous Tissue Substitute
    Fifth choice is value Z: No Device
  Seventh character (Qualifier) has 3 choices.
    First choice is value P: Foot Artery
    Second choice is value Q: Lower Extremity Artery
    Third choice is value S: Lower Extremity Vein

No change: Tenth panel of table 0 4 1
  Fourth character (Body Part) has 4 choices.
    First choice is value T: Peroneal Artery, Right
    Second choice is value U: Peroneal Artery, Left
    Third choice is value V: Foot Artery, Right
    Fourth choice is value W: Foot Artery, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device) is value J: Synthetic Substitute
  Seventh character (Qualifier) has 2 choices.
    First choice is value Q: Lower Extremity Artery
    Second choice is value S: Lower Extremity Vein

No change: table 0 4 7
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value 4: Lower Arteries
  Third character (Operation) is value 7: Dilation: Expanding an orifice or the lumen of a tubular body part

FY2025: First panel of table 0 4 7
  Fourth character (Body Part) has 21 choices.
    First choice is value 0: Abdominal Aorta
    Second choice is value 1: Celiac Artery
    Third choice is value 2: Gastric Artery
    Fourth choice is value 3: Hepatic Artery
    Fifth choice is value 4: Splenic Artery
    Sixth choice is value 5: Superior Mesenteric Artery
    Seventh choice is value 6: Colic Artery, Right
    Eighth choice is value 7: Colic Artery, Left
    Ninth choice is value 8: Colic Artery, Middle
    Tenth choice is value 9: Renal Artery, Right
    Eleventh choice is value A: Renal Artery, Left
    Twelfth choice is value B: Inferior Mesenteric Artery
    Thirteenth choice is value C: Common Iliac Artery, Right
    Fourteenth choice is value D: Common Iliac Artery, Left
    Fifteenth choice is value E: Internal Iliac Artery, Right
    Sixteenth choice is value F: Internal Iliac Artery, Left
    Seventeenth choice is value H: External Iliac Artery, Right
    Eighteenth choice is value J: External Iliac Artery, Left
    Nineteenth choice is value V: Foot Artery, Right
    Twentieth choice is value W: Foot Artery, Left
    Twenty-first choice is value Y: Lower Artery
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 3 choices.
    First choice is value 4: Intraluminal Device, Drug-eluting
    Second choice is value D: Intraluminal Device
    Third choice is value Z: No Device
  Seventh character (Qualifier) has 2 choices.
    First choice is value 1: Drug-Coated Balloon
    Second choice is value Z: No Qualifier

FY2025: Second panel of table 0 4 7
  Fourth character (Body Part) has 21 choices.
    First choice is value 0: Abdominal Aorta
    Second choice is value 1: Celiac Artery
    Third choice is value 2: Gastric Artery
    Fourth choice is value 3: Hepatic Artery
    Fifth choice is value 4: Splenic Artery
    Sixth choice is value 5: Superior Mesenteric Artery
    Seventh choice is value 6: Colic Artery, Right
    Eighth choice is value 7: Colic Artery, Left
    Ninth choice is value 8: Colic Artery, Middle
    Tenth choice is value 9: Renal Artery, Right
    Eleventh choice is value A: Renal Artery, Left
    Twelfth choice is value B: Inferior Mesenteric Artery
    Thirteenth choice is value C: Common Iliac Artery, Right
    Fourteenth choice is value D: Common Iliac Artery, Left
    Fifteenth choice is value E: Internal Iliac Artery, Right
    Sixteenth choice is value F: Internal Iliac Artery, Left
    Seventeenth choice is value H: External Iliac Artery, Right
    Eighteenth choice is value J: External Iliac Artery, Left
    Nineteenth choice is value V: Foot Artery, Right
    Twentieth choice is value W: Foot Artery, Left
    Twenty-first choice is value Y: Lower Artery
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 6 choices.
    First choice is value 5: Intraluminal Device, Drug-eluting, Two
    Second choice is value 6: Intraluminal Device, Drug-eluting, Three
    Third choice is value 7: Intraluminal Device, Drug-eluting, Four or More
    Fourth choice is value E: Intraluminal Device, Two
    Fifth choice is value F: Intraluminal Device, Three
    Sixth choice is value G: Intraluminal Device, Four or More
  Seventh character (Qualifier) is value Z: No Qualifier

FY2025: Third panel of table 0 4 7
  Fourth character (Body Part) has 10 choices.
    First choice is value K: Femoral Artery, Right
    Second choice is value L: Femoral Artery, Left
    Third choice is value M: Popliteal Artery, Right
    Fourth choice is value N: Popliteal Artery, Left
    Fifth choice is value P: Anterior Tibial Artery, Right
    Sixth choice is value Q: Anterior Tibial Artery, Left
    Seventh choice is value R: Posterior Tibial Artery, Right
    Eighth choice is value S: Posterior Tibial Artery, Left
    Ninth choice is value T: Peroneal Artery, Right
    Tenth choice is value U: Peroneal Artery, Left
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 3 choices.
    First choice is value 4: Intraluminal Device, Drug-eluting
    Second choice is value D: Intraluminal Device
    Third choice is value Z: No Device
  Seventh character (Qualifier) has 2 choices.
    First choice is value 1: Drug-Coated Balloon
    Second choice is value Z: No Qualifier

FY2025: Fourth panel of table 0 4 7
  Fourth character (Body Part) has 10 choices.
    First choice is value K: Femoral Artery, Right
    Second choice is value L: Femoral Artery, Left
    Third choice is value M: Popliteal Artery, Right
    Fourth choice is value N: Popliteal Artery, Left
    Fifth choice is value P: Anterior Tibial Artery, Right
    Sixth choice is value Q: Anterior Tibial Artery, Left
    Seventh choice is value R: Posterior Tibial Artery, Right
    Eighth choice is value S: Posterior Tibial Artery, Left
    Ninth choice is value T: Peroneal Artery, Right
    Tenth choice is value U: Peroneal Artery, Left
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 6 choices.
    First choice is value 5: Intraluminal Device, Drug-eluting, Two
    Second choice is value 6: Intraluminal Device, Drug-eluting, Three
    Third choice is value 7: Intraluminal Device, Drug-eluting, Four or More
    Fourth choice is value E: Intraluminal Device, Two
    Fifth choice is value F: Intraluminal Device, Three
    Sixth choice is value G: Intraluminal Device, Four or More
  Seventh character (Qualifier) is value Z: No Qualifier

FY2025: Fifth panel of table 0 4 7
  Fourth character (Body Part) has 10 choices.
    First choice is value K: Femoral Artery, Right
    Second choice is value L: Femoral Artery, Left
    Third choice is value M: Popliteal Artery, Right
    Fourth choice is value N: Popliteal Artery, Left
    Fifth choice is value P: Anterior Tibial Artery, Right
    Sixth choice is value Q: Anterior Tibial Artery, Left
    Seventh choice is value R: Posterior Tibial Artery, Right
    Eighth choice is value S: Posterior Tibial Artery, Left
    Ninth choice is value T: Peroneal Artery, Right
    Tenth choice is value U: Peroneal Artery, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device) is value 4: Intraluminal Device, Drug-eluting
  Seventh character (Qualifier) has 3 choices.
    First choice is value 1: Drug-Coated Balloon
    Second choice is value 2: Sustained Release
    Third choice is value Z: No Qualifier

FY2025: Sixth panel of table 0 4 7
  Fourth character (Body Part) has 10 choices.
    First choice is value K: Femoral Artery, Right
    Second choice is value L: Femoral Artery, Left
    Third choice is value M: Popliteal Artery, Right
    Fourth choice is value N: Popliteal Artery, Left
    Fifth choice is value P: Anterior Tibial Artery, Right
    Sixth choice is value Q: Anterior Tibial Artery, Left
    Seventh choice is value R: Posterior Tibial Artery, Right
    Eighth choice is value S: Posterior Tibial Artery, Left
    Ninth choice is value T: Peroneal Artery, Right
    Tenth choice is value U: Peroneal Artery, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device) has 3 choices.
    First choice is value 5: Intraluminal Device, Drug-eluting, Two
    Second choice is value 6: Intraluminal Device, Drug-eluting, Three
    Third choice is value 7: Intraluminal Device, Drug-eluting, Four or More
  Seventh character (Qualifier) has 2 choices.
    First choice is value 2: Sustained Release
    Second choice is value Z: No Qualifier

FY2025: Seventh panel of table 0 4 7
  Fourth character (Body Part) has 10 choices.
    First choice is value K: Femoral Artery, Right
    Second choice is value L: Femoral Artery, Left
    Third choice is value M: Popliteal Artery, Right
    Fourth choice is value N: Popliteal Artery, Left
    Fifth choice is value P: Anterior Tibial Artery, Right
    Sixth choice is value Q: Anterior Tibial Artery, Left
    Seventh choice is value R: Posterior Tibial Artery, Right
    Eighth choice is value S: Posterior Tibial Artery, Left
    Ninth choice is value T: Peroneal Artery, Right
    Tenth choice is value U: Peroneal Artery, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device) has 2 choices.
    First choice is value D: Intraluminal Device
    Second choice is value Z: No Device
  Seventh character (Qualifier) has 2 choices.
    First choice is value 1: Drug-Coated Balloon
    Second choice is value Z: No Qualifier

FY2025: Eighth panel of table 0 4 7
  Fourth character (Body Part) has 10 choices.
    First choice is value K: Femoral Artery, Right
    Second choice is value L: Femoral Artery, Left
    Third choice is value M: Popliteal Artery, Right
    Fourth choice is value N: Popliteal Artery, Left
    Fifth choice is value P: Anterior Tibial Artery, Right
    Sixth choice is value Q: Anterior Tibial Artery, Left
    Seventh choice is value R: Posterior Tibial Artery, Right
    Eighth choice is value S: Posterior Tibial Artery, Left
    Ninth choice is value T: Peroneal Artery, Right
    Tenth choice is value U: Peroneal Artery, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device) has 3 choices.
    First choice is value E: Intraluminal Device, Two
    Second choice is value F: Intraluminal Device, Three
    Third choice is value G: Intraluminal Device, Four or More
  Seventh character (Qualifier) is value Z: No Qualifier

FY2025: table 0 7 1
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value 7: Lymphatic and Hemic Systems
  Third character (Operation) is value 1: Bypass: Altering the route of passage of the contents of a tubular body part

FY2025: First panel of table 0 7 1
  Fourth character (Body Part) has 19 choices.
    First choice is value 0: Lymphatic, Head
    Second choice is value 1: Lymphatic, Right Neck
    Third choice is value 2: Lymphatic, Left Neck
    Fourth choice is value 3: Lymphatic, Right Upper Extremity
    Fifth choice is value 4: Lymphatic, Left Upper Extremity
    Sixth choice is value 5: Lymphatic, Right Axillary
    Seventh choice is value 6: Lymphatic, Left Axillary
    Eighth choice is value 7: Lymphatic, Thorax
    Ninth choice is value 8: Lymphatic, Internal Mammary, Right
    Tenth choice is value 9: Lymphatic, Internal Mammary, Left
    Eleventh choice is value B: Lymphatic, Mesenteric
    Twelfth choice is value C: Lymphatic, Pelvis
    Thirteenth choice is value D: Lymphatic, Aortic
    Fourteenth choice is value F: Lymphatic, Right Lower Extremity
    Fifteenth choice is value G: Lymphatic, Left Lower Extremity
    Sixteenth choice is value H: Lymphatic, Right Inguinal
    Seventeenth choice is value J: Lymphatic, Left Inguinal
    Eighteenth choice is value K: Thoracic Duct
    Nineteenth choice is value L: Cisterna Chyli
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) is value Z: No Device
  Seventh character (Qualifier) has 5 choices.
    First choice is value 3: Peripheral Vein
    Second choice is value 4: Central Vein
    Third choice is value 7: Lymphatic
    Fourth choice is value K: Thoracic Duct
    Fifth choice is value L: Cisterna Chyli

No change: table 0 F P
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value F: Hepatobiliary System and Pancreas
  Third character (Operation) is value P: Removal: Taking out or off a device from a body part

No change: First panel of table 0 F P
  Fourth character (Body Part) is value 0: Liver
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 4 choices.
    First choice is value 0: Drainage Device
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
    Fourth choice is value Y: Other Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Second panel of table 0 F P
  Fourth character (Body Part) is value 0: Liver
  Fifth character (Approach) is value X: External
  Sixth character (Device) has 3 choices.
    First choice is value 0: Drainage Device
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Third panel of table 0 F P
  Fourth character (Body Part) has 2 choices.
    First choice is value 4: Gallbladder
    Second choice is value G: Pancreas
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 5 choices.
    First choice is value 0: Drainage Device
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
    Fourth choice is value D: Intraluminal Device
    Fifth choice is value Y: Other Device
  Seventh character (Qualifier) is value Z: No Qualifier

FY2025: Fourth panel of table 0 F P
  Fourth character (Body Part) has 2 choices.
    First choice is value 4: Gallbladder
    Second choice is value G: Pancreas
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Device) is value 0: Drainage Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Fifth panel of table 0 F P
  Fourth character (Body Part) has 2 choices.
    First choice is value 4: Gallbladder
    Second choice is value G: Pancreas
  Fifth character (Approach) is value X: External
  Sixth character (Device) has 4 choices.
    First choice is value 0: Drainage Device
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
    Fourth choice is value D: Intraluminal Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Sixth panel of table 0 F P
  Fourth character (Body Part) has 2 choices.
    First choice is value B: Hepatobiliary Duct
    Second choice is value D: Pancreatic Duct
  Fifth character (Approach) has 5 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
    Fourth choice is value 7: Via Natural or Artificial Opening
    Fifth choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Device) has 10 choices.
    First choice is value 0: Drainage Device
    Second choice is value 1: Radioactive Element
    Third choice is value 2: Monitoring Device
    Fourth choice is value 3: Infusion Device
    Fifth choice is value 7: Autologous Tissue Substitute
    Sixth choice is value C: Extraluminal Device
    Seventh choice is value D: Intraluminal Device
    Eighth choice is value J: Synthetic Substitute
    Ninth choice is value K: Nonautologous Tissue Substitute
    Tenth choice is value Y: Other Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Seventh panel of table 0 F P
  Fourth character (Body Part) has 2 choices.
    First choice is value B: Hepatobiliary Duct
    Second choice is value D: Pancreatic Duct
  Fifth character (Approach) is value X: External
  Sixth character (Device) has 5 choices.
    First choice is value 0: Drainage Device
    Second choice is value 1: Radioactive Element
    Third choice is value 2: Monitoring Device
    Fourth choice is value 3: Infusion Device
    Fifth choice is value D: Intraluminal Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: table 0 F W
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value F: Hepatobiliary System and Pancreas
  Third character (Operation) is value W: Revision: Correcting, to the extent possible, a portion of a malfunctioning device or the position of a displaced device

No change: First panel of table 0 F W
  Fourth character (Body Part) is value 0: Liver
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 4 choices.
    First choice is value 0: Drainage Device
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
    Fourth choice is value Y: Other Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Second panel of table 0 F W
  Fourth character (Body Part) is value 0: Liver
  Fifth character (Approach) is value X: External
  Sixth character (Device) has 3 choices.
    First choice is value 0: Drainage Device
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Third panel of table 0 F W
  Fourth character (Body Part) has 2 choices.
    First choice is value 4: Gallbladder
    Second choice is value G: Pancreas
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 5 choices.
    First choice is value 0: Drainage Device
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
    Fourth choice is value D: Intraluminal Device
    Fifth choice is value Y: Other Device
  Seventh character (Qualifier) is value Z: No Qualifier

FY2025: Fourth panel of table 0 F W
  Fourth character (Body Part) has 2 choices.
    First choice is value 4: Gallbladder
    Second choice is value G: Pancreas
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Device) is value 0: Drainage Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Fifth panel of table 0 F W
  Fourth character (Body Part) has 2 choices.
    First choice is value 4: Gallbladder
    Second choice is value G: Pancreas
  Fifth character (Approach) is value X: External
  Sixth character (Device) has 4 choices.
    First choice is value 0: Drainage Device
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
    Fourth choice is value D: Intraluminal Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Sixth panel of table 0 F W
  Fourth character (Body Part) has 2 choices.
    First choice is value B: Hepatobiliary Duct
    Second choice is value D: Pancreatic Duct
  Fifth character (Approach) has 5 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
    Fourth choice is value 7: Via Natural or Artificial Opening
    Fifth choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Device) has 9 choices.
    First choice is value 0: Drainage Device
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
    Fourth choice is value 7: Autologous Tissue Substitute
    Fifth choice is value C: Extraluminal Device
    Sixth choice is value D: Intraluminal Device
    Seventh choice is value J: Synthetic Substitute
    Eighth choice is value K: Nonautologous Tissue Substitute
    Ninth choice is value Y: Other Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Seventh panel of table 0 F W
  Fourth character (Body Part) has 2 choices.
    First choice is value B: Hepatobiliary Duct
    Second choice is value D: Pancreatic Duct
  Fifth character (Approach) is value X: External
  Sixth character (Device) has 8 choices.
    First choice is value 0: Drainage Device
    Second choice is value 2: Monitoring Device
    Third choice is value 3: Infusion Device
    Fourth choice is value 7: Autologous Tissue Substitute
    Fifth choice is value C: Extraluminal Device
    Sixth choice is value D: Intraluminal Device
    Seventh choice is value J: Synthetic Substitute
    Eighth choice is value K: Nonautologous Tissue Substitute
  Seventh character (Qualifier) is value Z: No Qualifier

No change: table 0 H R
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value H: Skin and Breast
  Third character (Operation) is value R: Replacement: Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part

No change: First panel of table 0 H R
  Fourth character (Body Part) has 23 choices.
    First choice is value 0: Skin, Scalp
    Second choice is value 1: Skin, Face
    Third choice is value 2: Skin, Right Ear
    Fourth choice is value 3: Skin, Left Ear
    Fifth choice is value 4: Skin, Neck
    Sixth choice is value 5: Skin, Chest
    Seventh choice is value 6: Skin, Back
    Eighth choice is value 7: Skin, Abdomen
    Ninth choice is value 8: Skin, Buttock
    Tenth choice is value 9: Skin, Perineum
    Eleventh choice is value A: Skin, Inguinal
    Twelfth choice is value B: Skin, Right Upper Arm
    Thirteenth choice is value C: Skin, Left Upper Arm
    Fourteenth choice is value D: Skin, Right Lower Arm
    Fifteenth choice is value E: Skin, Left Lower Arm
    Sixteenth choice is value F: Skin, Right Hand
    Seventeenth choice is value G: Skin, Left Hand
    Eighteenth choice is value H: Skin, Right Upper Leg
    Nineteenth choice is value J: Skin, Left Upper Leg
    Twentieth choice is value K: Skin, Right Lower Leg
    Twenty-first choice is value L: Skin, Left Lower Leg
    Twenty-second choice is value M: Skin, Right Foot
    Twenty-third choice is value N: Skin, Left Foot
  Fifth character (Approach) is value X: External
  Sixth character (Device) is value 7: Autologous Tissue Substitute
  Seventh character (Qualifier) has 3 choices.
    First choice is value 2: Cell Suspension Technique
    Second choice is value 3: Full Thickness
    Third choice is value 4: Partial Thickness

No change: Second panel of table 0 H R
  Fourth character (Body Part) has 23 choices.
    First choice is value 0: Skin, Scalp
    Second choice is value 1: Skin, Face
    Third choice is value 2: Skin, Right Ear
    Fourth choice is value 3: Skin, Left Ear
    Fifth choice is value 4: Skin, Neck
    Sixth choice is value 5: Skin, Chest
    Seventh choice is value 6: Skin, Back
    Eighth choice is value 7: Skin, Abdomen
    Ninth choice is value 8: Skin, Buttock
    Tenth choice is value 9: Skin, Perineum
    Eleventh choice is value A: Skin, Inguinal
    Twelfth choice is value B: Skin, Right Upper Arm
    Thirteenth choice is value C: Skin, Left Upper Arm
    Fourteenth choice is value D: Skin, Right Lower Arm
    Fifteenth choice is value E: Skin, Left Lower Arm
    Sixteenth choice is value F: Skin, Right Hand
    Seventeenth choice is value G: Skin, Left Hand
    Eighteenth choice is value H: Skin, Right Upper Leg
    Nineteenth choice is value J: Skin, Left Upper Leg
    Twentieth choice is value K: Skin, Right Lower Leg
    Twenty-first choice is value L: Skin, Left Lower Leg
    Twenty-second choice is value M: Skin, Right Foot
    Twenty-third choice is value N: Skin, Left Foot
  Fifth character (Approach) is value X: External
  Sixth character (Device) is value J: Synthetic Substitute
  Seventh character (Qualifier) has 3 choices.
    First choice is value 3: Full Thickness
    Second choice is value 4: Partial Thickness
    Third choice is value Z: No Qualifier

No change: Third panel of table 0 H R
  Fourth character (Body Part) has 23 choices.
    First choice is value 0: Skin, Scalp
    Second choice is value 1: Skin, Face
    Third choice is value 2: Skin, Right Ear
    Fourth choice is value 3: Skin, Left Ear
    Fifth choice is value 4: Skin, Neck
    Sixth choice is value 5: Skin, Chest
    Seventh choice is value 6: Skin, Back
    Eighth choice is value 7: Skin, Abdomen
    Ninth choice is value 8: Skin, Buttock
    Tenth choice is value 9: Skin, Perineum
    Eleventh choice is value A: Skin, Inguinal
    Twelfth choice is value B: Skin, Right Upper Arm
    Thirteenth choice is value C: Skin, Left Upper Arm
    Fourteenth choice is value D: Skin, Right Lower Arm
    Fifteenth choice is value E: Skin, Left Lower Arm
    Sixteenth choice is value F: Skin, Right Hand
    Seventeenth choice is value G: Skin, Left Hand
    Eighteenth choice is value H: Skin, Right Upper Leg
    Nineteenth choice is value J: Skin, Left Upper Leg
    Twentieth choice is value K: Skin, Right Lower Leg
    Twenty-first choice is value L: Skin, Left Lower Leg
    Twenty-second choice is value M: Skin, Right Foot
    Twenty-third choice is value N: Skin, Left Foot
  Fifth character (Approach) is value X: External
  Sixth character (Device) is value K: Nonautologous Tissue Substitute
  Seventh character (Qualifier) has 2 choices.
    First choice is value 3: Full Thickness
    Second choice is value 4: Partial Thickness

No change: Fourth panel of table 0 H R
  Fourth character (Body Part) has 3 choices.
    First choice is value Q: Finger Nail
    Second choice is value R: Toe Nail
    Third choice is value S: Hair
  Fifth character (Approach) is value X: External
  Sixth character (Device) has 3 choices.
    First choice is value 7: Autologous Tissue Substitute
    Second choice is value J: Synthetic Substitute
    Third choice is value K: Nonautologous Tissue Substitute
  Seventh character (Qualifier) is value Z: No Qualifier

FY2025: Fifth panel of table 0 H R
  Fourth character (Body Part) has 3 choices.
    First choice is value T: Breast, Right
    Second choice is value U: Breast, Left
    Third choice is value V: Breast, Bilateral
  Fifth character (Approach) is value 0: Open
  Sixth character (Device) is value 7: Autologous Tissue Substitute
  Seventh character (Qualifier) has 7 choices.
    First choice is value 5: Latissimus Dorsi Myocutaneous Flap
    Second choice is value 6: Transverse Rectus Abdominis Myocutaneous Flap
    Third choice is value 7: Deep Inferior Epigastric Artery Perforator Flap
    Fourth choice is value 8: Superficial Inferior Epigastric Artery Flap
    Fifth choice is value 9: Gluteal Artery Perforator Flap
    Sixth choice is value B: Lumbar Artery Perforator Flap
    Seventh choice is value Z: No Qualifier

No change: Sixth panel of table 0 H R
  Fourth character (Body Part) has 3 choices.
    First choice is value T: Breast, Right
    Second choice is value U: Breast, Left
    Third choice is value V: Breast, Bilateral
  Fifth character (Approach) is value 0: Open
  Sixth character (Device) has 2 choices.
    First choice is value J: Synthetic Substitute
    Second choice is value K: Nonautologous Tissue Substitute
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Seventh panel of table 0 H R
  Fourth character (Body Part) has 3 choices.
    First choice is value T: Breast, Right
    Second choice is value U: Breast, Left
    Third choice is value V: Breast, Bilateral
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device) has 3 choices.
    First choice is value 7: Autologous Tissue Substitute
    Second choice is value J: Synthetic Substitute
    Third choice is value K: Nonautologous Tissue Substitute
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Eighth panel of table 0 H R
  Fourth character (Body Part) has 2 choices.
    First choice is value W: Nipple, Right
    Second choice is value X: Nipple, Left
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value X: External
  Sixth character (Device) has 3 choices.
    First choice is value 7: Autologous Tissue Substitute
    Second choice is value J: Synthetic Substitute
    Third choice is value K: Nonautologous Tissue Substitute
  Seventh character (Qualifier) is value Z: No Qualifier

No change: table 0 N P
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value N: Head and Facial Bones
  Third character (Operation) is value P: Removal: Taking out or off a device from a body part

No change: First panel of table 0 N P
  Fourth character (Body Part) is value 0: Skull
  Fifth character (Approach) is value 0: Open
  Sixth character (Device) has 10 choices.
    First choice is value 0: Drainage Device
    Second choice is value 3: Infusion Device
    Third choice is value 4: Internal Fixation Device
    Fourth choice is value 5: External Fixation Device
    Fifth choice is value 7: Autologous Tissue Substitute
    Sixth choice is value J: Synthetic Substitute
    Seventh choice is value K: Nonautologous Tissue Substitute
    Eighth choice is value M: Bone Growth Stimulator
    Ninth choice is value N: Neurostimulator Generator
    Tenth choice is value S: Hearing Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Second panel of table 0 N P
  Fourth character (Body Part) is value 0: Skull
  Fifth character (Approach) has 2 choices.
    First choice is value 3: Percutaneous
    Second choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 9 choices.
    First choice is value 0: Drainage Device
    Second choice is value 3: Infusion Device
    Third choice is value 4: Internal Fixation Device
    Fourth choice is value 5: External Fixation Device
    Fifth choice is value 7: Autologous Tissue Substitute
    Sixth choice is value J: Synthetic Substitute
    Seventh choice is value K: Nonautologous Tissue Substitute
    Eighth choice is value M: Bone Growth Stimulator
    Ninth choice is value S: Hearing Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Third panel of table 0 N P
  Fourth character (Body Part) is value 0: Skull
  Fifth character (Approach) is value X: External
  Sixth character (Device) has 6 choices.
    First choice is value 0: Drainage Device
    Second choice is value 3: Infusion Device
    Third choice is value 4: Internal Fixation Device
    Fourth choice is value 5: External Fixation Device
    Fifth choice is value M: Bone Growth Stimulator
    Sixth choice is value S: Hearing Device
  Seventh character (Qualifier) is value Z: No Qualifier

FY2025: Fourth panel of table 0 N P
  Fourth character (Body Part) has 2 choices.
    First choice is value B: Nasal Bone
    Second choice is value W: Facial Bone
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device) has 7 choices.
    First choice is value 0: Drainage Device
    Second choice is value 4: Internal Fixation Device
    Third choice is value 5: External Fixation Device
    Fourth choice is value 7: Autologous Tissue Substitute
    Fifth choice is value J: Synthetic Substitute
    Sixth choice is value K: Nonautologous Tissue Substitute
    Seventh choice is value M: Bone Growth Stimulator
  Seventh character (Qualifier) is value Z: No Qualifier

FY2025: Fifth panel of table 0 N P
  Fourth character (Body Part) has 2 choices.
    First choice is value B: Nasal Bone
    Second choice is value W: Facial Bone
  Fifth character (Approach) is value X: External
  Sixth character (Device) has 4 choices.
    First choice is value 0: Drainage Device
    Second choice is value 4: Internal Fixation Device
    Third choice is value 5: External Fixation Device
    Fourth choice is value M: Bone Growth Stimulator
  Seventh character (Qualifier) is value Z: No Qualifier

No change: table 0 N W
  First character (Section) is value 0: Medical and Surgical
  Second character (Body System) is value N: Head and Facial Bones
  Third character (Operation) is value W: Revision: Correcting, to the extent possible, a portion of a malfunctioning device or the position of a displaced device

No change: First panel of table 0 N W
  Fourth character (Body Part) is value 0: Skull
  Fifth character (Approach) is value 0: Open
  Sixth character (Device) has 10 choices.
    First choice is value 0: Drainage Device
    Second choice is value 3: Infusion Device
    Third choice is value 4: Internal Fixation Device
    Fourth choice is value 5: External Fixation Device
    Fifth choice is value 7: Autologous Tissue Substitute
    Sixth choice is value J: Synthetic Substitute
    Seventh choice is value K: Nonautologous Tissue Substitute
    Eighth choice is value M: Bone Growth Stimulator
    Ninth choice is value N: Neurostimulator Generator
    Tenth choice is value S: Hearing Device
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Second panel of table 0 N W
  Fourth character (Body Part) is value 0: Skull
  Fifth character (Approach) has 3 choices.
    First choice is value 3: Percutaneous
    Second choice is value 4: Percutaneous Endoscopic
    Third choice is value X: External
  Sixth character (Device) has 9 choices.
    First choice is value 0: Drainage Device
    Second choice is value 3: Infusion Device
    Third choice is value 4: Internal Fixation Device
    Fourth choice is value 5: External Fixation Device
    Fifth choice is value 7: Autologous Tissue Substitute
    Sixth choice is value J: Synthetic Substitute
    Seventh choice is value K: Nonautologous Tissue Substitute
    Eighth choice is value M: Bone Growth Stimulator
    Ninth choice is value S: Hearing Device
  Seventh character (Qualifier) is value Z: No Qualifier

FY2025: Third panel of table 0 N W
  Fourth character (Body Part) has 2 choices.
    First choice is value B: Nasal Bone
    Second choice is value W: Facial Bone
  Fifth character (Approach) has 4 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
    Fourth choice is value X: External
  Sixth character (Device) has 7 choices.
    First choice is value 0: Drainage Device
    Second choice is value 4: Internal Fixation Device
    Third choice is value 5: External Fixation Device
    Fourth choice is value 7: Autologous Tissue Substitute
    Fifth choice is value J: Synthetic Substitute
    Sixth choice is value K: Nonautologous Tissue Substitute
    Seventh choice is value M: Bone Growth Stimulator
  Seventh character (Qualifier) is value Z: No Qualifier

No change: table 5 A 0
  First character (Section) is value 5: Extracorporeal or Systemic Assistance and Performance
  Second character (Body System) is value A: Physiological Systems
  Third character (Operation) is value 0: Assistance: Taking over a portion of a physiological function by extracorporeal means

No change: First panel of table 5 A 0
  Fourth character (Body System) is value 2: Cardiac
  Fifth character (Duration) is value 1: Intermittent
  Sixth character (Function) is value 1: Output
  Seventh character (Qualifier) has 4 choices.
    First choice is value 0: Balloon Pump
    Second choice is value 5: Pulsatile Compression
    Third choice is value 6: Other Pump
    Fourth choice is value D: Impeller Pump

No change: Second panel of table 5 A 0
  Fourth character (Body System) is value 2: Cardiac
  Fifth character (Duration) is value 2: Continuous
  Sixth character (Function) is value 1: Output
  Seventh character (Qualifier) has 4 choices.
    First choice is value 0: Balloon Pump
    Second choice is value 5: Pulsatile Compression
    Third choice is value 6: Other Pump
    Fourth choice is value D: Impeller Pump

No change: Third panel of table 5 A 0
  Fourth character (Body System) is value 2: Cardiac
  Fifth character (Duration) is value 2: Continuous
  Sixth character (Function) is value 2: Oxygenation
  Seventh character (Qualifier) is value C: Supersaturated

No change: Fourth panel of table 5 A 0
  Fourth character (Body System) is value 5: Circulatory
  Fifth character (Duration) has 2 choices.
    First choice is value 1: Intermittent
    Second choice is value 2: Continuous
  Sixth character (Function) is value 2: Oxygenation
  Seventh character (Qualifier) is value 1: Hyperbaric

FY2025: Fifth panel of table 5 A 0
  Fourth character (Body System) is value 5: Circulatory
  Fifth character (Duration) is value A: Intraoperative
  Sixth character (Function) is value 0: Filtration
  Seventh character (Qualifier) is value L: Peripheral Veno-venous

No change: Sixth panel of table 5 A 0
  Fourth character (Body System) is value 9: Respiratory
  Fifth character (Duration) is value 2: Continuous
  Sixth character (Function) is value 0: Filtration
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Seventh panel of table 5 A 0
  Fourth character (Body System) is value 9: Respiratory
  Fifth character (Duration) has 3 choices.
    First choice is value 3: Less than 24 Consecutive Hours
    Second choice is value 4: 24-96 Consecutive Hours
    Third choice is value 5: Greater than 96 Consecutive Hours
  Sixth character (Function) is value 5: Ventilation
  Seventh character (Qualifier) has 6 choices.
    First choice is value 7: Continuous Positive Airway Pressure
    Second choice is value 8: Intermittent Positive Airway Pressure
    Third choice is value 9: Continuous Negative Airway Pressure
    Fourth choice is value A: High Flow/Velocity Cannula
    Fifth choice is value B: Intermittent Negative Airway Pressure
    Sixth choice is value Z: No Qualifier

No change: Eighth panel of table 5 A 0
  Fourth character (Body System) is value 9: Respiratory
  Fifth character (Duration) has 3 choices.
    First choice is value B: Less than 8 Consecutive Hours
    Second choice is value C: 8-24 Consecutive Hours
    Third choice is value D: Greater than 24 Consecutive Hours
  Sixth character (Function) is value 5: Ventilation
  Seventh character (Qualifier) is value K: Intubated Prone Positioning

No change: table 8 E 0
  First character (Section) is value 8: Other Procedures
  Second character (Body System) is value E: Physiological Systems and Anatomical Regions
  Third character (Operation) is value 0: Other Procedures: Methodologies which attempt to remediate or cure a disorder or disease

No change: First panel of table 8 E 0
  Fourth character (Body Region) is value 1: Nervous System
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value Y: Other Method
  Seventh character (Qualifier) is value 7: Examination

FY2025: Second panel of table 8 E 0
  Fourth character (Body Region) is value 2: Circulatory System
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Method) has 2 choices.
    First choice is value D: Near Infrared Spectroscopy
    Second choice is value F: Fiber Optic 3D Guided Procedure
  Seventh character (Qualifier) is value Z: No Qualifier

FY2025: Third panel of table 8 E 0
  Fourth character (Body Region) is value 2: Circulatory System
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value D: Near Infrared Spectroscopy
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Fourth panel of table 8 E 0
  Fourth character (Body Region) is value 9: Head and Neck Region
  Fifth character (Approach) is value 0: Open
  Sixth character (Method) is value C: Robotic Assisted Procedure
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Fifth panel of table 8 E 0
  Fourth character (Body Region) is value 9: Head and Neck Region
  Fifth character (Approach) is value 0: Open
  Sixth character (Method) is value E: Fluorescence Guided Procedure
  Seventh character (Qualifier) has 2 choices.
    First choice is value M: Aminolevulinic Acid
    Second choice is value Z: No Qualifier

No change: Sixth panel of table 8 E 0
  Fourth character (Body Region) is value 9: Head and Neck Region
  Fifth character (Approach) has 4 choices.
    First choice is value 3: Percutaneous
    Second choice is value 4: Percutaneous Endoscopic
    Third choice is value 7: Via Natural or Artificial Opening
    Fourth choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Method) has 2 choices.
    First choice is value C: Robotic Assisted Procedure
    Second choice is value E: Fluorescence Guided Procedure
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Seventh panel of table 8 E 0
  Fourth character (Body Region) is value 9: Head and Neck Region
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value B: Computer Assisted Procedure
  Seventh character (Qualifier) has 4 choices.
    First choice is value F: With Fluoroscopy
    Second choice is value G: With Computerized Tomography
    Third choice is value H: With Magnetic Resonance Imaging
    Fourth choice is value Z: No Qualifier

No change: Eighth panel of table 8 E 0
  Fourth character (Body Region) is value 9: Head and Neck Region
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value C: Robotic Assisted Procedure
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Ninth panel of table 8 E 0
  Fourth character (Body Region) is value 9: Head and Neck Region
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value Y: Other Method
  Seventh character (Qualifier) is value 8: Suture Removal

No change: Tenth panel of table 8 E 0
  Fourth character (Body Region) is value H: Integumentary System and Breast
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Method) is value 0: Acupuncture
  Seventh character (Qualifier) has 2 choices.
    First choice is value 0: Anesthesia
    Second choice is value Z: No Qualifier

No change: Eleventh panel of table 8 E 0
  Fourth character (Body Region) is value H: Integumentary System and Breast
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value 6: Collection
  Seventh character (Qualifier) is value 2: Breast Milk

No change: Twelfth panel of table 8 E 0
  Fourth character (Body Region) is value H: Integumentary System and Breast
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value Y: Other Method
  Seventh character (Qualifier) is value 9: Piercing

No change: Thirteenth panel of table 8 E 0
  Fourth character (Body Region) is value K: Musculoskeletal System
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value 1: Therapeutic Massage
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Fourteenth panel of table 8 E 0
  Fourth character (Body Region) is value K: Musculoskeletal System
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value Y: Other Method
  Seventh character (Qualifier) is value 7: Examination

No change: Fifteenth panel of table 8 E 0
  Fourth character (Body Region) is value U: Female Reproductive System
  Fifth character (Approach) has 5 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
    Fourth choice is value 7: Via Natural or Artificial Opening
    Fifth choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Method) is value E: Fluorescence Guided Procedure
  Seventh character (Qualifier) is value N: Pafolacianine

No change: Sixteenth panel of table 8 E 0
  Fourth character (Body Region) is value U: Female Reproductive System
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value Y: Other Method
  Seventh character (Qualifier) is value 7: Examination

No change: Seventeenth panel of table 8 E 0
  Fourth character (Body Region) is value V: Male Reproductive System
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value 1: Therapeutic Massage
  Seventh character (Qualifier) has 2 choices.
    First choice is value C: Prostate
    Second choice is value D: Rectum

No change: Eighteenth panel of table 8 E 0
  Fourth character (Body Region) is value V: Male Reproductive System
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value 6: Collection
  Seventh character (Qualifier) is value 3: Sperm

No change: Nineteenth panel of table 8 E 0
  Fourth character (Body Region) is value W: Trunk Region
  Fifth character (Approach) has 5 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
    Fourth choice is value 7: Via Natural or Artificial Opening
    Fifth choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Method) is value C: Robotic Assisted Procedure
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Twentieth panel of table 8 E 0
  Fourth character (Body Region) is value W: Trunk Region
  Fifth character (Approach) has 5 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
    Fourth choice is value 7: Via Natural or Artificial Opening
    Fifth choice is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Method) is value E: Fluorescence Guided Procedure
  Seventh character (Qualifier) has 2 choices.
    First choice is value N: Pafolacianine
    Second choice is value Z: No Qualifier

No change: Twenty-first panel of table 8 E 0
  Fourth character (Body Region) is value W: Trunk Region
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value B: Computer Assisted Procedure
  Seventh character (Qualifier) has 4 choices.
    First choice is value F: With Fluoroscopy
    Second choice is value G: With Computerized Tomography
    Third choice is value H: With Magnetic Resonance Imaging
    Fourth choice is value Z: No Qualifier

No change: Twenty-second panel of table 8 E 0
  Fourth character (Body Region) is value W: Trunk Region
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value C: Robotic Assisted Procedure
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Twenty-third panel of table 8 E 0
  Fourth character (Body Region) is value W: Trunk Region
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value Y: Other Method
  Seventh character (Qualifier) is value 8: Suture Removal

No change: Twenty-fourth panel of table 8 E 0
  Fourth character (Body Region) has 2 choices.
    First choice is value X: Upper Extremity
    Second choice is value Y: Lower Extremity
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Method) has 2 choices.
    First choice is value C: Robotic Assisted Procedure
    Second choice is value E: Fluorescence Guided Procedure
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Twenty-fifth panel of table 8 E 0
  Fourth character (Body Region) has 2 choices.
    First choice is value X: Upper Extremity
    Second choice is value Y: Lower Extremity
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value B: Computer Assisted Procedure
  Seventh character (Qualifier) has 4 choices.
    First choice is value F: With Fluoroscopy
    Second choice is value G: With Computerized Tomography
    Third choice is value H: With Magnetic Resonance Imaging
    Fourth choice is value Z: No Qualifier

No change: Twenty-sixth panel of table 8 E 0
  Fourth character (Body Region) has 2 choices.
    First choice is value X: Upper Extremity
    Second choice is value Y: Lower Extremity
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value C: Robotic Assisted Procedure
  Seventh character (Qualifier) is value Z: No Qualifier

No change: Twenty-seventh panel of table 8 E 0
  Fourth character (Body Region) has 2 choices.
    First choice is value X: Upper Extremity
    Second choice is value Y: Lower Extremity
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value Y: Other Method
  Seventh character (Qualifier) is value 8: Suture Removal

No change: Twenty-eighth panel of table 8 E 0
  Fourth character (Body Region) is value Z: None
  Fifth character (Approach) is value X: External
  Sixth character (Method) is value Y: Other Method
  Seventh character (Qualifier) has 4 choices.
    First choice is value 1: In Vitro Fertilization
    Second choice is value 4: Yoga Therapy
    Third choice is value 5: Meditation
    Fourth choice is value 6: Isolation

No change: table X 0 5
  First character (Section) is value X: New Technology
  Second character (Body System) is value 0: Nervous System
  Third character (Operation) is value 5: Destruction: Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent

No change: First panel of table X 0 5
  Fourth character (Body Part) is value 1: Renal Sympathetic Nerve(s)
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 2: Ultrasound Ablation
  Seventh character (Qualifier) is value 9: New Technology Group 9

FY2025: Second panel of table X 0 5
  Fourth character (Body Part) is value 1: Renal Sympathetic Nerve(s)
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 3: Radiofrequency Ablation
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: table X 2 7
  First character (Section) is value X: New Technology
  Second character (Body System) is value 2: Cardiovascular System
  Third character (Operation) is value 7: Dilation: Expanding an orifice or the lumen of a tubular body part

FY2025: First panel of table X 2 7
  Fourth character (Body Part) has 6 choices.
    First choice is value P: Anterior Tibial Artery, Right
    Second choice is value Q: Anterior Tibial Artery, Left
    Third choice is value R: Posterior Tibial Artery, Right
    Fourth choice is value S: Posterior Tibial Artery, Left
    Fifth choice is value T: Peroneal Artery, Right
    Sixth choice is value U: Peroneal Artery, Left
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value T: Intraluminal Device, Everolimus-eluting Resorbable Scaffold(s)
  Seventh character (Qualifier) is value A: New Technology Group 10

FY2025: table X 2 8
  First character (Section) is value X: New Technology
  Second character (Body System) is value 2: Cardiovascular System
  Third character (Operation) is value 8: Division: Cutting into a body part, without draining fluids and/or gases from the body part, in order to separate or transect a body part

FY2025: First panel of table X 2 8
  Fourth character (Body Part) is value F: Aortic Valve
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value V: Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: table X 2 R
  First character (Section) is value X: New Technology
  Second character (Body System) is value 2: Cardiovascular System
  Third character (Operation) is value R: Replacement: Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part

FY2025: First panel of table X 2 R
  Fourth character (Body Part) has 4 choices.
    First choice is value 5: Upper Extremity Artery, Right
    Second choice is value 6: Upper Extremity Artery, Left
    Third choice is value 7: Lower Extremity Artery, Right
    Fourth choice is value 8: Lower Extremity Artery, Left
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value W: Bioengineered Human Acellular Vessel
  Seventh character (Qualifier) is value A: New Technology Group 10

FY2025: Second panel of table X 2 R
  Fourth character (Body Part) is value J: Tricuspid Valve
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value R: Multi-plane Flex Technology Bioprosthetic Valve
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Third panel of table X 2 R
  Fourth character (Body Part) is value X: Thoracic Aorta, Arch
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value N: Branched Synthetic Substitute with Intraluminal Device
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: table X 2 V
  First character (Section) is value X: New Technology
  Second character (Body System) is value 2: Cardiovascular System
  Third character (Operation) is value V: Restriction: Partially closing an orifice or the lumen of a tubular body part

No change: First panel of table X 2 V
  Fourth character (Body Part) is value 7: Coronary Sinus
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value Q: Reduction Device
  Seventh character (Qualifier) is value 7: New Technology Group 7

FY2025: Second panel of table X 2 V
  Fourth character (Body Part) is value E: Descending Thoracic Aorta and Abdominal Aorta
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value S: Branched Intraluminal Device, Manufactured Integrated System, Four or More Arteries
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Third panel of table X 2 V
  Fourth character (Body Part) is value W: Thoracic Aorta, Descending
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value N: Branched Synthetic Substitute with Intraluminal Device
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: table X H R
  First character (Section) is value X: New Technology
  Second character (Body System) is value H: Skin, Subcutaneous Tissue, Fascia and Breast
  Third character (Operation) is value R: Replacement: Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part

FY2025: First panel of table X H R
  Fourth character (Body Part) has 8 choices.
    First choice is value 0: Skin, Head and Neck
    Second choice is value 1: Skin, Chest
    Third choice is value 2: Skin, Abdomen
    Fourth choice is value 3: Skin, Back
    Fifth choice is value 4: Skin, Right Upper Extremity
    Sixth choice is value 5: Skin, Left Upper Extremity
    Seventh choice is value 6: Skin, Right Lower Extremity
    Eighth choice is value 7: Skin, Left Lower Extremity
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value G: Prademagene Zamikeracel, Genetically Engineered Autologous Cell Therapy
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Second panel of table X H R
  Fourth character (Body Part) is value P: Skin
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value F: Bioengineered Allogeneic Construct
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: table X R G
  First character (Section) is value X: New Technology
  Second character (Body System) is value R: Joints
  Third character (Operation) is value G: Fusion: Joining together portions of an articular body part rendering the articular body part immobile

FY2025: First panel of table X R G
  Fourth character (Body Part) is value A: Thoracolumbar Vertebral Joint
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value E: Facet Joint Fusion Device, Paired Titanium Cages
  Seventh character (Qualifier) is value A: New Technology Group 10

FY2025: Second panel of table X R G
  Fourth character (Body Part) is value A: Thoracolumbar Vertebral Joint
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device / Substance / Technology) is value R: Interbody Fusion Device, Custom-Made Anatomically Designed
  Seventh character (Qualifier) is value 7: New Technology Group 7

FY2025: Third panel of table X R G
  Fourth character (Body Part) is value B: Lumbar Vertebral Joint
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value E: Facet Joint Fusion Device, Paired Titanium Cages
  Seventh character (Qualifier) is value A: New Technology Group 10

FY2025: Fourth panel of table X R G
  Fourth character (Body Part) is value B: Lumbar Vertebral Joint
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device / Substance / Technology) is value R: Interbody Fusion Device, Custom-Made Anatomically Designed
  Seventh character (Qualifier) is value 7: New Technology Group 7

FY2025: Fifth panel of table X R G
  Fourth character (Body Part) is value C: Lumbar Vertebral Joints, 2 or more
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value E: Facet Joint Fusion Device, Paired Titanium Cages
  Seventh character (Qualifier) is value A: New Technology Group 10

FY2025: Sixth panel of table X R G
  Fourth character (Body Part) is value C: Lumbar Vertebral Joints, 2 or more
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device / Substance / Technology) is value R: Interbody Fusion Device, Custom-Made Anatomically Designed
  Seventh character (Qualifier) is value 7: New Technology Group 7

FY2025: Seventh panel of table X R G
  Fourth character (Body Part) is value D: Lumbosacral Joint
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value E: Facet Joint Fusion Device, Paired Titanium Cages
  Seventh character (Qualifier) is value A: New Technology Group 10

FY2025: Eighth panel of table X R G
  Fourth character (Body Part) is value D: Lumbosacral Joint
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device / Substance / Technology) is value R: Interbody Fusion Device, Custom-Made Anatomically Designed
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Ninth panel of table X R G
  Fourth character (Body Part) has 2 choices.
    First choice is value E: Sacroiliac Joint, Right
    Second choice is value F: Sacroiliac Joint, Left
  Fifth character (Approach) has 2 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 5: Internal Fixation Device with Tulip Connector
  Seventh character (Qualifier) is value 8: New Technology Group 8

FY2025: Tenth panel of table X R G
  Fourth character (Body Part) is value J: Ankle Joint, Right
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value B: Internal Fixation Device, Open-truss Design
  Seventh character (Qualifier) is value 9: New Technology Group 9

FY2025: Eleventh panel of table X R G
  Fourth character (Body Part) is value J: Ankle Joint, Right
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value C: Internal Fixation Device, Gyroid-Sheet Lattice Design
  Seventh character (Qualifier) is value A: New Technology Group 10

FY2025: Twelfth panel of table X R G
  Fourth character (Body Part) is value K: Ankle Joint, Left
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value B: Internal Fixation Device, Open-truss Design
  Seventh character (Qualifier) is value 9: New Technology Group 9

FY2025: Thirteenth panel of table X R G
  Fourth character (Body Part) is value K: Ankle Joint, Left
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value C: Internal Fixation Device, Gyroid-Sheet Lattice Design
  Seventh character (Qualifier) is value A: New Technology Group 10

FY2025: Fourteenth panel of table X R G
  Fourth character (Body Part) is value L: Tarsal Joint, Right
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value B: Internal Fixation Device, Open-truss Design
  Seventh character (Qualifier) is value 9: New Technology Group 9

FY2025: Fifteenth panel of table X R G
  Fourth character (Body Part) is value L: Tarsal Joint, Right
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value C: Internal Fixation Device, Gyroid-Sheet Lattice Design
  Seventh character (Qualifier) is value A: New Technology Group 10

FY2025: Sixteenth panel of table X R G
  Fourth character (Body Part) is value M: Tarsal Joint, Left
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value B: Internal Fixation Device, Open-truss Design
  Seventh character (Qualifier) is value 9: New Technology Group 9

FY2025: Seventeenth panel of table X R G
  Fourth character (Body Part) is value M: Tarsal Joint, Left
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value C: Internal Fixation Device, Gyroid-Sheet Lattice Design
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: table X R H
  First character (Section) is value X: New Technology
  Second character (Body System) is value R: Joints
  Third character (Operation) is value H: Insertion: Putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part

FY2025: First panel of table X R H
  Fourth character (Body Part) has 4 choices.
    First choice is value 6: Thoracic Vertebral Joint
    Second choice is value 7: Thoracic Vertebral Joints, 2 to 7
    Third choice is value 8: Thoracic Vertebral Joints, 8 or more
    Fourth choice is value A: Thoracolumbar Vertebral Joint
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device / Substance / Technology) is value F: Carbon/PEEK Spinal Stabilization Device, Pedicle Based
  Seventh character (Qualifier) is value A: New Technology Group 10

FY2025: Second panel of table X R H
  Fourth character (Body Part) is value B: Lumbar Vertebral Joint
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value 1: Posterior Spinal Motion Preservation Device
  Seventh character (Qualifier) is value 8: New Technology Group 8

FY2025: Third panel of table X R H
  Fourth character (Body Part) has 2 choices.
    First choice is value B: Lumbar Vertebral Joint
    Second choice is value C: Lumbar Vertebral Joints, 2 or more
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device / Substance / Technology) is value F: Carbon/PEEK Spinal Stabilization Device, Pedicle Based
  Seventh character (Qualifier) is value A: New Technology Group 10

FY2025: Fourth panel of table X R H
  Fourth character (Body Part) is value D: Lumbosacral Joint
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value 1: Posterior Spinal Motion Preservation Device
  Seventh character (Qualifier) is value 8: New Technology Group 8

FY2025: Fifth panel of table X R H
  Fourth character (Body Part) is value D: Lumbosacral Joint
  Fifth character (Approach) has 3 choices.
    First choice is value 0: Open
    Second choice is value 3: Percutaneous
    Third choice is value 4: Percutaneous Endoscopic
  Sixth character (Device / Substance / Technology) is value F: Carbon/PEEK Spinal Stabilization Device, Pedicle Based
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: table X W 0
  First character (Section) is value X: New Technology
  Second character (Body System) is value W: Anatomical Regions
  Third character (Operation) is value 0: Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

No change: First panel of table X W 0
  Fourth character (Body Part) is value 0: Skin
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 2: Anacaulase-bcdb
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Second panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 1: Daratumumab and Hyaluronidase-fihj
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Third panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 2: Talquetamab Antineoplastic
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Fourth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 4: Teclistamab Antineoplastic
  Seventh character (Qualifier) is value 8: New Technology Group 8

FY2025: Fifth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 6: Dasiglucagon
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Sixth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Satralizumab-mwge
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Seventh panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Other New Technology Therapeutic Substance
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Eighth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 3 choices.
    First choice is value G: REGN-COV2 Monoclonal Antibody
    Second choice is value H: Other New Technology Monoclonal Antibody
    Third choice is value K: Leronlimab Monoclonal Antibody
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Ninth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value L: Elranatamab Antineoplastic
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Tenth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value S: COVID-19 Vaccine Dose 1
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Eleventh panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value S: Epcoritamab Monoclonal Antibody
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Twelfth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value T: COVID-19 Vaccine Dose 2
    Second choice is value U: COVID-19 Vaccine
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Thirteenth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value V: COVID-19 Vaccine Dose 3
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Fourteenth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value W: Caplacizumab
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Fifteenth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value W: COVID-19 Vaccine Booster
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Sixteenth panel of table X W 0
  Fourth character (Body Part) is value 1: Subcutaneous Tissue
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 2: Anacaulase-bcdb
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Seventeenth panel of table X W 0
  Fourth character (Body Part) is value 2: Muscle
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value D: Engineered Allogeneic Thymus Tissue
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Eighteenth panel of table X W 0
  Fourth character (Body Part) is value 2: Muscle
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 3 choices.
    First choice is value S: COVID-19 Vaccine Dose 1
    Second choice is value T: COVID-19 Vaccine Dose 2
    Third choice is value U: COVID-19 Vaccine
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Nineteenth panel of table X W 0
  Fourth character (Body Part) is value 2: Muscle
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 4 choices.
    First choice is value V: COVID-19 Vaccine Dose 3
    Second choice is value W: COVID-19 Vaccine Booster
    Third choice is value X: Tixagevimab and Cilgavimab Monoclonal Antibody
    Fourth choice is value Y: Other New Technology Monoclonal Antibody
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Twentieth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 0: Brexanolone
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Twenty-first panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 0: Spesolimab Monoclonal Antibody
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Twenty-second panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value 2: Nerinitide
    Second choice is value 3: Durvalumab Antineoplastic
  Seventh character (Qualifier) is value 6: New Technology Group 6

FY2025: Twenty-third panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value 3: Bentracimab, Ticagrelor Reversal Agent
    Second choice is value 4: Cefepime-taniborbactam Anti-infective
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Twenty-fourth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 5: Narsoplimab Monoclonal Antibody
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Twenty-fifth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 5: Mosunetuzumab Antineoplastic
  Seventh character (Qualifier) is value 8: New Technology Group 8

FY2025: Twenty-sixth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 5: Ceftobiprole Medocaril Anti-infective
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Twenty-seventh panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 6: Lefamulin Anti-infective
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Twenty-eighth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 6: Terlipressin
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Twenty-ninth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 6: Afamitresgene Autoleucel Immunotherapy
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Thirtieth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Coagulation Factor Xa, Inactivated
  Seventh character (Qualifier) is value 2: New Technology Group 2

No change: Thirty-first panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Trilaciclib
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Thirty-second panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Tabelecleucel Immunotherapy
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Thirty-third panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 8: Lurbinectedin
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Thirty-fourth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 8: Treosulfan
  Seventh character (Qualifier) is value 8: New Technology Group 8

FY2025: Thirty-fifth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 8: Obecabtagene Autoleucel
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Thirty-sixth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Ceftolozane/Tazobactam Anti-infective
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Thirty-seventh panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Inebilizumab-cdon
  Seventh character (Qualifier) is value 8: New Technology Group 8

FY2025: Thirty-eighth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Odronextamab Antineoplastic
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Thirty-ninth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value A: Cefiderocol Anti-infective
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Fortieth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value A: Ciltacabtagene Autoleucel
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Forty-first panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Cytarabine and Daunorubicin Liposome Antineoplastic
  Seventh character (Qualifier) is value 3: New Technology Group 3

No change: Forty-second panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Omadacycline Anti-infective
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Forty-third panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Amivantamab Monoclonal Antibody
  Seventh character (Qualifier) is value 7: New Technology Group 7

FY2025: Forty-fourth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Orca-T Allogeneic T-cell Immunotherapy
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Forty-fifth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value C: Eculizumab
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Forty-sixth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value C: Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
  Seventh character (Qualifier) is value 7: New Technology Group 7

FY2025: Forty-seventh panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value C: Zanidatamab Antineoplastic
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Forty-eighth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value D: Atezolizumab Antineoplastic
  Seventh character (Qualifier) is value 6: New Technology Group 6

FY2025: Forty-ninth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value D: Donislecel-jujn Allogeneic Pancreatic Islet Cellular Suspension
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Fiftieth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value E: Remdesivir Anti-infective
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Fifty-first panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value E: Etesevimab Monoclonal Antibody
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Fifty-second panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Other New Technology Therapeutic Substance
  Seventh character (Qualifier) is value 3: New Technology Group 3

No change: Fifty-third panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Other New Technology Therapeutic Substance
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Fifty-fourth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Bamlanivimab Monoclonal Antibody
  Seventh character (Qualifier) is value 6: New Technology Group 6

FY2025: Fifty-fifth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Fifty-sixth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value G: Sarilumab
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Fifty-seventh panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value G: REGN-COV2 Monoclonal Antibody
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Fifty-eighth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value G: Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Fifty-ninth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value H: Tocilizumab
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Sixtieth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value H: Other New Technology Monoclonal Antibody
  Seventh character (Qualifier) is value 6: New Technology Group 6

FY2025: Sixty-first panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 3 choices.
    First choice is value H: Axicabtagene Ciloleucel Immunotherapy
    Second choice is value J: Tisagenlecleucel Immunotherapy
    Third choice is value K: Idecabtagene Vicleucel Immunotherapy
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Sixty-second panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value K: Sulbactam-Durlobactam
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Sixty-third panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value L: CD24Fc Immunomodulator
  Seventh character (Qualifier) is value 6: New Technology Group 6

FY2025: Sixty-fourth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 3 choices.
    First choice is value L: Lifileucel Immunotherapy
    Second choice is value M: Brexucabtagene Autoleucel Immunotherapy
    Third choice is value N: Lisocabtagene Maraleucel Immunotherapy
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Sixty-fifth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value P: Glofitamab Antineoplastic
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Sixty-sixth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value Q: Tagraxofusp-erzs Antineoplastic
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Sixty-seventh panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value Q: Posoleucel
    Second choice is value R: Rezafungin
  Seventh character (Qualifier) is value 9: New Technology Group 9

FY2025: Sixty-eighth panel of table X W 0
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value S: Iobenguane I-131 Antineoplastic
    Second choice is value W: Caplacizumab
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Sixty-ninth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 0: Brexanolone
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Seventieth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 0: Spesolimab Monoclonal Antibody
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Seventy-first panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value 2: Nerinitide
    Second choice is value 3: Durvalumab Antineoplastic
  Seventh character (Qualifier) is value 6: New Technology Group 6

FY2025: Seventy-second panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value 3: Bentracimab, Ticagrelor Reversal Agent
    Second choice is value 4: Cefepime-taniborbactam Anti-infective
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Seventy-third panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 5: Narsoplimab Monoclonal Antibody
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Seventy-fourth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 5: Mosunetuzumab Antineoplastic
  Seventh character (Qualifier) is value 8: New Technology Group 8

FY2025: Seventy-fifth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 5: Ceftobiprole Medocaril Anti-infective
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Seventy-sixth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 6: Lefamulin Anti-infective
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Seventy-seventh panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 6: Terlipressin
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Seventy-eighth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 6: Afamitresgene Autoleucel Immunotherapy
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Seventy-ninth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Coagulation Factor Xa, Inactivated
  Seventh character (Qualifier) is value 2: New Technology Group 2

No change: Eightieth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Trilaciclib
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Eighty-first panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Tabelecleucel Immunotherapy
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Eighty-second panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 8: Lurbinectedin
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Eighty-third panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 8: Treosulfan
  Seventh character (Qualifier) is value 8: New Technology Group 8

FY2025: Eighty-fourth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 8: Obecabtagene Autoleucel
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Eighty-fifth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Ceftolozane/Tazobactam Anti-infective
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Eighty-sixth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Inebilizumab-cdon
  Seventh character (Qualifier) is value 8: New Technology Group 8

FY2025: Eighty-seventh panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 9: Odronextamab Antineoplastic
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Eighty-eighth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value A: Cefiderocol Anti-infective
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Eighty-ninth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value A: Ciltacabtagene Autoleucel
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Ninetieth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Cytarabine and Daunorubicin Liposome Antineoplastic
  Seventh character (Qualifier) is value 3: New Technology Group 3

No change: Ninety-first panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Omadacycline Anti-infective
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Ninety-second panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Amivantamab Monoclonal Antibody
  Seventh character (Qualifier) is value 7: New Technology Group 7

FY2025: Ninety-third panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value B: Orca-T Allogeneic T-cell Immunotherapy
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Ninety-fourth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value C: Eculizumab
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Ninety-fifth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value C: Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
  Seventh character (Qualifier) is value 7: New Technology Group 7

FY2025: Ninety-sixth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value C: Zanidatamab Antineoplastic
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Ninety-seventh panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value D: Atezolizumab Antineoplastic
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Ninety-eighth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value E: Remdesivir Anti-infective
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: Ninety-ninth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value E: Etesevimab Monoclonal Antibody
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundredth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Other New Technology Therapeutic Substance
  Seventh character (Qualifier) is value 3: New Technology Group 3

No change: One hundred First panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Other New Technology Therapeutic Substance
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: One hundred Second panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Bamlanivimab Monoclonal Antibody
  Seventh character (Qualifier) is value 6: New Technology Group 6

FY2025: One hundred Third panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value F: Non-Chimeric Antigen Receptor T-cell Immune Effector Cell Therapy
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: One hundred Fourth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value G: Sarilumab
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: One hundred Fifth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value G: REGN-COV2 Monoclonal Antibody
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred Sixth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value G: Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: One hundred Seventh panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value H: Tocilizumab
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: One hundred Eighth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value H: Other New Technology Monoclonal Antibody
  Seventh character (Qualifier) is value 6: New Technology Group 6

FY2025: One hundred Ninth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 3 choices.
    First choice is value H: Axicabtagene Ciloleucel Immunotherapy
    Second choice is value J: Tisagenlecleucel Immunotherapy
    Third choice is value K: Idecabtagene Vicleucel Immunotherapy
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: One hundred Tenth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value K: Sulbactam-Durlobactam
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: One hundred Eleventh panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value L: CD24Fc Immunomodulator
  Seventh character (Qualifier) is value 6: New Technology Group 6

FY2025: One hundred Twelfth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 3 choices.
    First choice is value L: Lifileucel Immunotherapy
    Second choice is value M: Brexucabtagene Autoleucel Immunotherapy
    Third choice is value N: Lisocabtagene Maraleucel Immunotherapy
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: One hundred Thirteenth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value P: Glofitamab Antineoplastic
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: One hundred Fourteenth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value Q: Tagraxofusp-erzs Antineoplastic
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: One hundred Fifteenth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value Q: Posoleucel
    Second choice is value R: Rezafungin
  Seventh character (Qualifier) is value 9: New Technology Group 9

FY2025: One hundred Sixteenth panel of table X W 0
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value S: Iobenguane I-131 Antineoplastic
    Second choice is value W: Caplacizumab
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: One hundred Seventeenth panel of table X W 0
  Fourth character (Body Part) is value 5: Peripheral Artery
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value T: Melphalan Hydrochloride Antineoplastic
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: One hundred Eighteenth panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 3: Maribavir Anti-infective
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: One hundred Nineteenth panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 6: Lefamulin Anti-infective
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred Twentieth panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 8: Uridine Triacetate
  Seventh character (Qualifier) is value 2: New Technology Group 2

FY2025: One hundred Twenty-first panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value F: Other New Technology Therapeutic Substance
  Seventh character (Qualifier) is value 5: New Technology Group 5

No change: One hundred Twenty-second panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value J: Quizartinib Antineoplastic
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: One hundred Twenty-third panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value K: Sabizabulin
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: One hundred Twenty-fourth panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value M: Baricitinib
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred Twenty-fifth panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value N: SER-109
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: One hundred Twenty-sixth panel of table X W 0
  Fourth character (Body Part) is value D: Mouth and Pharynx
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value R: Fostamatinib
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: One hundred Twenty-seventh panel of table X W 0
  Fourth character (Body Part) is value G: Upper GI
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value 3: Maribavir Anti-infective
    Second choice is value K: Sabizabulin
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: One hundred Twenty-eighth panel of table X W 0
  Fourth character (Body Part) is value G: Upper GI
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) is value M: Baricitinib
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred Twenty-ninth panel of table X W 0
  Fourth character (Body Part) is value G: Upper GI
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) is value R: Fostamatinib
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: One hundred Thirtieth panel of table X W 0
  Fourth character (Body Part) is value G: Upper GI
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Device / Substance / Technology) is value 8: Mineral-based Topical Hemostatic Agent
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred Thirty-first panel of table X W 0
  Fourth character (Body Part) is value H: Lower GI
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value 3: Maribavir Anti-infective
    Second choice is value K: Sabizabulin
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: One hundred Thirty-second panel of table X W 0
  Fourth character (Body Part) is value H: Lower GI
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) is value M: Baricitinib
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: One hundred Thirty-third panel of table X W 0
  Fourth character (Body Part) is value H: Lower GI
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) is value R: Fostamatinib
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: One hundred Thirty-fourth panel of table X W 0
  Fourth character (Body Part) is value H: Lower GI
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) is value X: Broad Consortium Microbiota-based Live Biotherapeutic Suspension
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: One hundred Thirty-fifth panel of table X W 0
  Fourth character (Body Part) is value H: Lower GI
  Fifth character (Approach) is value 8: Via Natural or Artificial Opening Endoscopic
  Sixth character (Device / Substance / Technology) is value 8: Mineral-based Topical Hemostatic Agent
  Seventh character (Qualifier) is value 6: New Technology Group 6

FY2025: One hundred Thirty-sixth panel of table X W 0
  Fourth character (Body Part) has 4 choices.
    First choice is value J: Coronary Artery, One Artery
    Second choice is value K: Coronary Artery, Two Arteries
    Third choice is value L: Coronary Artery, Three Arteries
    Fourth choice is value M: Coronary Artery, Four or More Arteries
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 4 choices.
    First choice is value H: Paclitaxel-Coated Balloon Technology, One Balloon
    Second choice is value J: Paclitaxel-Coated Balloon Technology, Two Balloons
    Third choice is value K: Paclitaxel-Coated Balloon Technology, Three Balloons
    Fourth choice is value L: Paclitaxel-Coated Balloon Technology, Four or More Balloons
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: One hundred Thirty-seventh panel of table X W 0
  Fourth character (Body Part) is value Q: Cranial Cavity and Brain
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 1: Eladocagene exuparvovec
  Seventh character (Qualifier) is value 6: New Technology Group 6

FY2025: One hundred Thirty-eighth panel of table X W 0
  Fourth character (Body Part) is value U: Joints
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value G: Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: One hundred Thirty-ninth panel of table X W 0
  Fourth character (Body Part) is value V: Bones
  Fifth character (Approach) is value 0: Open
  Sixth character (Device / Substance / Technology) is value P: Antibiotic-eluting Bone Void Filler
  Seventh character (Qualifier) is value 7: New Technology Group 7

FY2025: One hundred Fortieth panel of table X W 0
  Fourth character (Body Part) is value V: Bones
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value W: AGN1 Bone Void Filler
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: table X W 1
  First character (Section) is value X: New Technology
  Second character (Body System) is value W: Anatomical Regions
  Third character (Operation) is value 1: Transfusion: Putting in blood or blood products

No change: First panel of table X W 1
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 2: Plasma, Convalescent (Nonautologous)
  Seventh character (Qualifier) is value 5: New Technology Group 5

FY2025: Second panel of table X W 1
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Marnetegragene Autotemcel
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Third panel of table X W 1
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value B: Betibeglogene Autotemcel
    Second choice is value C: Omidubicel
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Fourth panel of table X W 1
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value D: High-Dose Intravenous Immune Globulin
    Second choice is value E: Hyperimmune Globulin
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Fifth panel of table X W 1
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value F: OTL-103
    Second choice is value G: OTL-200
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Sixth panel of table X W 1
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value H: Lovotibeglogene Autotemcel
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Seventh panel of table X W 1
  Fourth character (Body Part) is value 3: Peripheral Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value J: Exagamglogene Autotemcel
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Eighth panel of table X W 1
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 2: Plasma, Convalescent (Nonautologous)
  Seventh character (Qualifier) is value 5: New Technology Group 5

FY2025: Ninth panel of table X W 1
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 7: Marnetegragene Autotemcel
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Tenth panel of table X W 1
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value B: Betibeglogene Autotemcel
    Second choice is value C: Omidubicel
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Eleventh panel of table X W 1
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value D: High-Dose Intravenous Immune Globulin
    Second choice is value E: Hyperimmune Globulin
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Twelfth panel of table X W 1
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value F: OTL-103
    Second choice is value G: OTL-200
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Thirteenth panel of table X W 1
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value H: Lovotibeglogene Autotemcel
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Fourteenth panel of table X W 1
  Fourth character (Body Part) is value 4: Central Vein
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value J: Exagamglogene Autotemcel
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: table X X 2
  First character (Section) is value X: New Technology
  Second character (Body System) is value X: Physiological Systems
  Third character (Operation) is value 2: Monitoring: Determining the level of a physiological or physical function repetitively over a period of time

No change: First panel of table X X 2
  Fourth character (Body Part) is value 0: Central Nervous
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 8: Brain Electrical Activity, Computer-aided Detection and Notification
  Seventh character (Qualifier) is value 9: New Technology Group 9

FY2025: Second panel of table X X 2
  Fourth character (Body Part) is value 5: Circulatory
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 0: Blood Flow, Adhesive Ultrasound Patch Technology
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Third panel of table X X 2
  Fourth character (Body Part) is value F: Musculoskeletal
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value W: Muscle Compartment Pressure, Micro-Electro-Mechanical System
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Fourth panel of table X X 2
  Fourth character (Body Part) is value K: Subcutaneous Tissue
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value P: Interstitial Fluid Volume, Sub-Epidermal Moisture using Electrical Biocapacitance
  Seventh character (Qualifier) is value 9: New Technology Group 9

FY2025: table X X A
  First character (Section) is value X: New Technology
  Second character (Body System) is value X: Physiological Systems
  Third character (Operation) is value A: Assistance: Taking over a portion of a physiological function by extracorporeal means

FY2025: First panel of table X X A
  Fourth character (Body Part) is value 5: Circulatory
  Fifth character (Approach) is value 3: Percutaneous
  Sixth character (Device / Substance / Technology) is value 6: Filtration, Blood Pathogens
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: table X X E
  First character (Section) is value X: New Technology
  Second character (Body System) is value X: Physiological Systems
  Third character (Operation) is value E: Measurement: Determining the level of a physiological or physical function at a point in time

No change: First panel of table X X E
  Fourth character (Body Part) is value 0: Central Nervous
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 0: Intracranial Vascular Activity, Computer-aided Assessment
  Seventh character (Qualifier) is value 7: New Technology Group 7

FY2025: Second panel of table X X E
  Fourth character (Body Part) is value 0: Central Nervous
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 1: Intracranial Cerebrospinal Fluid Flow, Computer-aided Triage and Notification
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Third panel of table X X E
  Fourth character (Body Part) is value 0: Central Nervous
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 4: Brain Electrical Activity, Computer-aided Semiologic Analysis
  Seventh character (Qualifier) is value 8: New Technology Group 8

No change: Fourth panel of table X X E
  Fourth character (Body Part) is value 2: Cardiac
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 1: Output, Computer-aided Assessment
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Fifth panel of table X X E
  Fourth character (Body Part) is value 3: Arterial
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 2: Pulmonary Artery Flow, Computer-aided Triage and Notification
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Sixth panel of table X X E
  Fourth character (Body Part) is value 3: Arterial
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) has 2 choices.
    First choice is value 5: Coronary Artery Flow, Quantitative Flow Ratio Analysis
    Second choice is value 6: Coronary Artery Flow, Computer-aided Valve Modeling and Notification
  Seventh character (Qualifier) is value 8: New Technology Group 8

FY2025: Seventh panel of table X X E
  Fourth character (Body Part) is value 5: Circulatory
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 2: Infection, Phenotypic Fully Automated Rapid Susceptibility Technology with Controlled Inoculum
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Eighth panel of table X X E
  Fourth character (Body Part) is value 5: Circulatory
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 3: Infection, Whole Blood Reverse Transcription and Quantitative Real-time Polymerase Chain Reaction
  Seventh character (Qualifier) is value 8: New Technology Group 8

FY2025: Ninth panel of table X X E
  Fourth character (Body Part) is value 5: Circulatory
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value 4: Infection, Positive Blood Culture Small Molecule Sensor Array Technology
  Seventh character (Qualifier) is value A: New Technology Group 10

No change: Tenth panel of table X X E
  Fourth character (Body Part) is value 5: Circulatory
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value N: Infection, Positive Blood Culture Fluorescence Hybridization for Organism Identification, Concentration and Susceptibility
  Seventh character (Qualifier) is value 6: New Technology Group 6

No change: Eleventh panel of table X X E
  Fourth character (Body Part) is value 5: Circulatory
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) has 3 choices.
    First choice is value R: Infection, Mechanical Initial Specimen Diversion Technique Using Active Negative Pressure
    Second choice is value T: Intracranial Arterial Flow, Whole Blood mRNA
    Third choice is value V: Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Twelfth panel of table X X E
  Fourth character (Body Part) is value 5: Circulatory
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value Y: Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology
  Seventh character (Qualifier) is value 9: New Technology Group 9

No change: Thirteenth panel of table X X E
  Fourth character (Body Part) is value 9: Nose
  Fifth character (Approach) is value 7: Via Natural or Artificial Opening
  Sixth character (Device / Substance / Technology) is value U: Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction
  Seventh character (Qualifier) is value 7: New Technology Group 7

No change: Fourteenth panel of table X X E
  Fourth character (Body Part) is value B: Respiratory
  Fifth character (Approach) is value X: External
  Sixth character (Device / Substance / Technology) is value Q: Infection, Lower Respiratory Fluid Nucleic Acid-base Microbial Detection
  Seventh character (Qualifier) is value 6: New Technology Group 6
